Dosage and administration
5 drops 2 or 3 times per day, on an empty stomach, 5 days per week until symptoms abate. Consult a physician for use in children under 12 years of age.
5 drops 2 or 3 times per day, on an empty stomach, 5 days per week until symptoms abate. Consult a physician for use in children under 12 years of age.
Cochlearia Armoracia 3X, Spleen (Bovine) 8X, Thymus Gland (Bovine) 8X, 1LM, Influenzinum 10X, 12X, 30X, 30C, 100C, 200C, Mycoplasma Pneumoniae 12X, 25, 30X, 200X, Cytomegalovirus 12X, 15X, 30X, 30C, 3LM, HPV 12X, 28X, 30C, 100C, 200C, 3LM, Coxsackie B1 8C, 9C, 12C, 15C, 30C, Coxsackie B4 8C, 9C, 12C, 15C, 30C, Pneumococcinum 30C, Carcinosin 30C, 200C, 3LM.
Fatigue, fever, cough, flu-like symptoms, heart palpitations, virus, pain, swelling and stiffness of limbs.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in a cool, dry place.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
5 drops 2 or 3 times per day, on an empty stomach, 5 days per week until symptoms abate.
Consult a physician for use in children under 12 years of age.
Fatigue, fever, cough, flu-like symptoms, heart palpitations, virus, pain, swelling and stiffness of limbs.
Demineralized Water, 25% Ethanol
MFD FOR:
The Wellness Center for Research
and Education, Inc.
1237 S. Victoria Ave. Suite 169
Oxnard, CA 93035
1-866-962-6484
Dr. Theresa Dale's
NDC: 50181-0028-1
Homeopathic
BioTox
Vi
1 fl oz (30 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50181-0028-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-28ce-f424-e053-dadaa90a57ce | DRUG FACTS: |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BOS TAURUS SPLEEN | ACTIVE INGREDIENT | 190Q9MB3U3 | 1 | |
| BOS TAURUS THYMUS | ACTIVE INGREDIENT | 8XEJ88V2T8 | 1 | |
| HORSERADISH | ACTIVE INGREDIENT | 8DS6G120HJ | 1 | |
| HUMAN BREAST TUMOR CELL | ACTIVE INGREDIENT | C62OO7VD9K | 1 | |
| HUMAN COXSACKIEVIRUS B1 | ACTIVE INGREDIENT | ADL68M27WD | 1 | |
| HUMAN COXSACKIEVIRUS B4 | ACTIVE INGREDIENT | FYF75V7FDY | 1 | |
| HUMAN HERPESVIRUS 5 | ACTIVE INGREDIENT | 7COI029E6K | 1 | |
| HUMAN PAPILLOMAVIRUS | ACTIVE INGREDIENT | 23CVL7WF4J | 1 | |
| INFLUENZA A VIRUS | ACTIVE INGREDIENT | R9HH0NDE2E | 1 | |
| INFLUENZA B VIRUS | ACTIVE INGREDIENT | 1314JZ2X6W | 1 | |
| MYCOPLASMA PNEUMONIAE | ACTIVE INGREDIENT | JQE470FAD0 | 1 | |
| STREPTOCOCCUS PNEUMONIAE | ACTIVE INGREDIENT | BT6U234YR2 | 1 | |
| BOS TAURUS SPLEEN | ACTIVE MOIETY | 190Q9MB3U3 | 1 | |
| BOS TAURUS THYMUS | ACTIVE MOIETY | 8XEJ88V2T8 | 1 | |
| HORSERADISH | ACTIVE MOIETY | 8DS6G120HJ | 1 | |
| HUMAN BREAST TUMOR CELL | ACTIVE MOIETY | C62OO7VD9K | 1 | |
| HUMAN COXSACKIEVIRUS B1 | ACTIVE MOIETY | ADL68M27WD | 1 | |
| HUMAN COXSACKIEVIRUS B4 | ACTIVE MOIETY | FYF75V7FDY | 1 | |
| HUMAN HERPESVIRUS 5 | ACTIVE MOIETY | 7COI029E6K | 1 | |
| HUMAN PAPILLOMAVIRUS | ACTIVE MOIETY | 23CVL7WF4J | 1 | |
| INFLUENZA A VIRUS | ACTIVE MOIETY | R9HH0NDE2E | 1 | |
| INFLUENZA B VIRUS | ACTIVE MOIETY | 1314JZ2X6W | 1 | |
| MYCOPLASMA PNEUMONIAE | ACTIVE MOIETY | JQE470FAD0 | 1 | |
| STREPTOCOCCUS PNEUMONIAE | ACTIVE MOIETY | BT6U234YR2 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50181-0028 | 50181-0028-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HORSERADISH | 8DS6G120HJ | ACTIB |
| BOS TAURUS SPLEEN | 190Q9MB3U3 | ACTIB |
| BOS TAURUS THYMUS | 8XEJ88V2T8 | ACTIB |
| INFLUENZA A VIRUS | R9HH0NDE2E | ACTIB |
| INFLUENZA B VIRUS | 1314JZ2X6W | ACTIB |
| MYCOPLASMA PNEUMONIAE | JQE470FAD0 | ACTIB |
| HUMAN HERPESVIRUS 5 | 7COI029E6K | ACTIB |
| HUMAN PAPILLOMAVIRUS | 23CVL7WF4J | ACTIB |
| HUMAN COXSACKIEVIRUS B1 | ADL68M27WD | ACTIB |
| HUMAN COXSACKIEVIRUS B4 | FYF75V7FDY | ACTIB |
| STREPTOCOCCUS PNEUMONIAE | BT6U234YR2 | ACTIB |
| HUMAN BREAST TUMOR CELL | C62OO7VD9K | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b33e90a7-b975-489e-9b8c-25f4f9498a18 | d6755c9c-3e2e-434d-ab18-944d693be31a | 2025-05-29 | Warnings | b33e90a7-b975-489e-9b8c-25f4f9498a18 d6755c9c-3e2e-434d-ab18-944d693be31a |
Adverse event summaries are temporarily unavailable. Other product information remains available.